sever
acut
respiratori
syndrom
sar
vaccin
current
test
clinic
trial
consist
inactiv
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
howev
limit
inform
avail
host
immun
respons
induc
inactiv
sar
vaccin
studi
demonstr
sarscov
inactiv
bpropiolacton
elicit
high
titer
antibodi
immun
mice
rabbit
recogn
spike
protein
especi
receptorbind
domain
rbd
region
antisera
immun
anim
effici
bound
rbd
block
bind
rbd
angiotensinconvert
enzym
function
receptor
suscept
cell
sarscov
sensit
quantit
singlecycl
infect
assay
use
pseudoviru
bear
sarscov
protein
demonstr
mous
rabbit
antisera
significantli
inhibit
proteinmedi
viru
entri
mean
inhibitori
titer
respect
data
suggest
rbd
protein
major
neutral
determin
inactiv
sar
vaccin
induc
potent
neutral
antibodi
block
sarscov
entri
howev
caution
taken
use
inactiv
sarscov
vaccin
sinc
may
also
caus
harm
immun
andor
inflammatori
respons
global
outbreak
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sarscov
result
cumul
total
case
death
countri
wwwwhointcsrsarsen
new
sar
case
report
south
china
earli
suggest
deadli
viru
may
recur
futur
therefor
highli
imper
develop
effect
safe
vaccin
prevent
control
new
sar
epidem
current
number
sar
vaccin
candid
includ
inactiv
sarscov
vaccin
dna
vaccin
attenu
viru
vaccin
express
sarscov
specif
protein
develop
among
inactiv
sarscov
vaccin
one
test
clinic
trial
china
although
sever
report
show
sarscov
inactiv
formaldehyd
uv
light
bpropiolacton
induc
viru
neutral
antibodi
immun
anim
host
immun
respons
induc
inactiv
viru
well
character
similar
coronavirus
sarscov
envelop
positivestrand
rna
viru
featur
larg
viral
genom
encod
replicas
polyprotein
spike
envelop
e
matrix
glycoprotein
nucleocapsid
protein
n
small
protein
unknown
function
expect
vaccin
inactiv
sarscov
vaccin
elicit
antibodi
respons
number
viral
protein
therefor
necessari
determin
viru
protein
major
antigen
respons
elicit
neutral
antibodi
protein
sarscov
larg
transmembran
glycoprotein
contain
domain
residu
domain
residu
respons
receptor
bind
membran
fusion
respect
entri
sarscov
target
cell
initi
bind
domain
angiotensinconvert
enzym
function
receptor
sarscov
suscept
cell
domain
chang
conform
associ
heptad
repeat
region
form
sixhelix
bundl
result
fusion
viral
envelop
target
cell
membran
shown
small
fragment
residu
region
minim
receptorbind
domain
rbd
recent
studi
demonstr
protein
sarscov
major
induc
neutral
antibodi
among
structur
protein
protein
express
dna
vaccin
attenu
vaccinia
viru
parainfluenza
viru
elicit
protect
immun
viru
challeng
recent
shown
protein
sarscov
contain
sever
immunodomin
domain
induc
neutral
antibodi
rbd
region
highli
potent
induc
neutral
antibodi
immun
anim
studi
demonstr
mice
rabbit
immun
inactiv
sarscov
vaccin
develop
signific
antibodi
respons
protein
especi
rbd
region
antisera
abl
effici
block
receptor
bind
inhibit
viru
entri
target
cell
recombin
sarscov
spike
protein
plasmid
encod
protein
domain
residu
tag
cterminu
design
plasmid
encod
acid
fragment
rbd
residu
link
fc
domain
human
design
rbdfc
kindli
provid
dr
farzan
harvard
medic
school
rbdfc
protein
express
cell
transfect
plasmid
use
fugen
reagent
boehringermannheim
indianapoli
accord
protocol
supernat
harvest
h
posttransfect
purifi
affin
chromatographi
mab
nation
cell
cultur
center
minneapoli
mn
rbdfc
purifi
protein
asepharos
fast
flow
amersham
bioscienc
piscataway
nj
fulllength
protein
express
expressf
insect
cell
infect
recombin
baculoviru
purchas
protein
scienc
bridgeport
ct
prepar
inactiv
sarscov
sarscov
strain
genbank
access
propag
vero
cell
describ
previous
infect
cell
harvest
complet
lyse
three
cycl
freezethaw
bpropiolacton
sigmaaldrich
st
loui
mo
ad
lysat
ratio
incub
h
inactiv
viru
centrifug
rpm
min
remov
cell
debri
supernat
desalt
sephadex
concentr
filter
sepharosecl
sequenti
inactiv
sarscov
final
prepar
puriti
analyz
hplc
confirm
observ
coronaviruslik
particl
electron
microscop
determin
reactiv
convalesc
sera
sar
patient
western
blot
immun
mice
rabbit
four
balbc
mice
four
nzw
rabbit
primarili
immun
intraderm
lg
purifi
viral
particl
inactiv
bpropiolacton
respect
immunogen
presenc
complet
adjuv
fca
boost
twice
amount
freshli
prepar
emuls
immunogen
incomplet
adjuv
fia
interv
preimmun
sera
preimmun
collect
start
immun
antisera
collect
day
second
boost
enzymelink
immunosorb
assay
mous
rabbit
sera
test
recombin
protein
protein
rbdfc
enzymelink
immunosorb
assay
elisa
briefli
lg
ml
recombin
protein
coat
microtit
plate
corn
costar
acton
carbon
buffer
ph
overnight
block
nonfat
milk
serial
dilut
mous
rabbit
sera
ad
incub
h
follow
three
wash
pb
contain
tween
bound
antibodi
detect
hrpconjug
goat
antimous
igg
goat
antirabbit
igg
zyme
south
san
francisco
ca
h
follow
wash
reaction
visual
addit
substrat
tetramethylbenzidin
tmb
absorb
nm
measur
elisa
plate
reader
tecan
us
research
triangl
park
nc
mous
rabbit
sera
reactiv
sarscov
test
elisa
commerci
avail
diagnost
kit
use
mixtur
protein
purifi
viral
lysat
coat
antigen
beij
genom
institut
beij
china
receptorbind
assay
inhibitori
effect
mous
rabbit
antisera
rbdfc
bind
receptor
test
use
elisabas
assay
briefli
recombin
solubl
r
system
minneapoli
mn
coat
lgml
elisa
plate
corn
costar
carbon
buffer
ph
overnight
block
nonfat
milk
lgml
rbdfc
ad
well
presenc
absenc
serial
dilut
mous
rabbit
sera
incub
h
hrpconjug
goat
antihuman
igg
zyme
substrat
tmb
use
detect
singlecycl
sar
pseudoviru
infect
assay
sar
pseudoviru
bear
sarscov
protein
defect
genom
express
luciferas
report
prepar
previous
describ
brief
cell
cotransfect
plasmid
encod
codonoptim
sarscov
protein
plasmid
encod
envdefect
luciferaseexpress
genom
use
fugen
reagent
boehringermannheim
supernat
contain
sar
pseudoviru
harvest
h
posttransfect
use
singlecycl
infect
briefli
cell
plate
cellswel
tissuecultur
plate
grown
overnight
supernat
contain
pseudoviru
preincub
serial
dilut
mous
rabbit
sera
h
addit
cell
cultur
refe
fresh
medium
h
later
incub
addit
h
cell
wash
pb
lyse
use
lysi
reagent
includ
luciferas
kit
promega
madison
wi
aliquot
cell
lysat
transfer
costar
flatbottom
luminomet
plate
corn
costar
corn
ny
follow
addit
luciferas
substrat
promega
rel
light
unit
rlu
determin
immedi
ultra
luminomet
tecan
us
inactiv
sarscov
induc
high
titer
proteinspecif
antibodi
mice
rabbit
sarscov
particl
inactiv
bpropiolacton
use
immun
mice
rabbit
three
immun
immun
mice
rabbit
develop
high
level
antibodi
respons
sarscov
detect
elisa
commerci
avail
diagnost
kit
use
mixtur
protein
purifi
viral
lysat
coat
antigen
mean
endpoint
titer
mous
rabbit
antisera
respect
preimmun
sera
mice
rabbit
react
viral
antigen
fig
determin
antibodi
respons
specif
sarscov
protein
immun
mice
rabbit
recombin
fulllength
protein
use
antigen
elisa
data
fig
indic
mice
rabbit
immun
inactiv
virus
develop
high
titer
antibodi
protein
mean
endpoint
titer
mous
rabbit
antisera
respect
expect
antibodi
react
protein
may
contain
antibodi
popul
spe
fig
antibodi
respons
sarscov
immun
mice
rabbit
b
mous
rabbit
sera
test
seri
dilut
commerci
diagnost
elisa
kit
use
mixtur
protein
purifi
viral
lysat
coat
antigen
cific
region
sinc
major
antigen
determin
protein
therefor
use
recombin
antigen
elisa
found
antibodi
titer
compar
fulllength
protein
fig
determin
whether
antisera
react
rbd
within
region
sinc
function
domain
protein
respons
mediat
viru
bind
receptor
contain
neutral
epitop
rbdfc
fusion
protein
use
coat
antigen
elisa
test
reactiv
mous
rabbit
antisera
strikingli
mous
rabbit
antisera
highli
reactiv
rbdfc
mean
endpoint
titer
respect
fig
similar
level
respons
fulllength
protein
suggest
rbd
protein
inactiv
sarscov
vaccin
prepar
major
antigen
determin
capabl
induc
potent
antibodi
respons
immun
anim
sarscov
infect
initi
attach
protein
via
rbd
region
cellular
receptor
interest
investig
whether
mous
rabbit
antisera
contain
rbdspecif
antibodi
block
receptor
bind
activ
determin
elisa
use
solubl
previous
describ
shown
fig
rbdfc
bound
dosedepend
manner
mous
rabbit
antisera
dilut
could
effect
block
bind
rbdfc
wherea
preimmun
sera
dilut
inhibitori
effect
receptor
bind
fig
c
result
indic
inactiv
sarscov
vaccin
induc
antibodi
specif
rbd
capabl
block
receptor
bind
investig
whether
antibodi
induc
inactiv
sarscov
immun
mice
rabbit
inhibit
proteinmedi
viru
entri
develop
sensit
quantit
safe
singlecycl
infect
assay
use
sar
pseudoviru
bear
sarscov
protein
shown
fig
mous
rabbit
antisera
dilut
significantli
inhibit
sar
pseudoviru
infect
wherea
preimmun
sera
dilut
inhibitori
effect
proteinmedi
viru
entri
mous
rabbit
antisera
inhibit
viru
entri
dosedepend
manner
mean
inhibitori
titer
respect
result
confirm
inactiv
sarscov
vaccin
elicit
proteinspecif
neutral
antibodi
immun
anim
although
outbreak
sar
success
contain
aggress
quarantin
measur
sar
may
reemerg
futur
prior
experi
infecti
diseas
control
suggest
vaccin
one
effect
measur
prevent
sar
epidem
gener
inactiv
viru
consid
first
gener
vaccin
prevent
viral
infecti
diseas
therefor
inactiv
sarscov
vaccin
develop
one
major
vaccin
candid
recent
vaccin
prepar
whole
sarscov
inactiv
bpropiolacton
test
clinic
trial
china
howev
seriou
concern
efficaci
safeti
human
sinc
antigen
properti
inactiv
sarscov
clearli
defin
studi
demonstr
inactiv
sarscov
abl
induc
high
titer
antibodi
specif
protein
especi
rbd
region
immun
mice
rabbit
suggest
protein
inactiv
sar
vaccin
prepar
maintain
high
immunogen
mice
rabbit
crucial
develop
inactiv
sarscov
vaccin
sinc
shown
protein
sarscov
major
antigen
capabl
induc
neutral
antibodi
protect
immun
recent
shown
rbd
major
antigen
determin
sarscov
protein
rbd
induc
high
titer
sarscov
neutral
antibodi
demonstr
inactiv
sarscov
vaccin
abl
induc
high
titer
antibodi
rbd
suggest
domain
correctli
fold
vaccin
prepar
retain
appropri
epitop
conform
elicit
neutral
antibodi
antibodi
antisera
mice
rabbit
immun
inactiv
sarscov
could
effect
block
rbd
bind
receptor
potent
inhibit
proteinmedi
viru
entri
suscept
cell
indic
antibodi
immun
anim
specif
rbd
protein
respons
inhibit
sarscov
entri
although
rbd
protein
sarscov
induc
potent
neutral
activ
safeti
inactiv
sarscov
vaccin
fulli
evalu
test
human
clinic
trial
protein
also
contain
immunodomin
domain
elicit
nonneutr
antibodi
protein
felin
infecti
periton
viru
fipv
coronaviru
induc
antibodi
immun
anim
neutral
rather
enhanc
infect
viru
challeng
addit
protein
coronavirus
also
contain
protein
may
induc
humor
cellular
immun
respons
exacerb
patholog
coronaviru
infect
protein
sarscov
may
induc
harm
immun
andor
inflammatori
respons
potenti
caus
sar
pathogenesi
report
sarscov
infect
ferret
caus
mild
liver
inflamm
liver
damag
becam
much
seriou
ferret
immun
vaccinia
virusbas
sar
vaccin
viru
challeng
recent
wang
lu
report
inactiv
sarscov
vaccin
trigger
autoimmun
respons
carbohydr
moieti
abund
human
serum
glycoprotein
asialoorosomucoid
therefor
caution
taken
applic
inactiv
sarscov
vaccin
prevent
sar
antigen
induc
harm
immun
andor
inflammatori
respons
identifi
remov
vaccin
prepar
contain
rbd
protein
may
serv
one
effect
safest
vaccin
prevent
sar
summari
first
descript
inactiv
sarscov
vaccin
induc
high
titer
antibodi
rbd
region
protein
rbdspecif
antibodi
antisera
effici
block
receptor
bind
viru
entri
data
provid
import
inform
understand
antigen
immunogen
sarscov
develop
antisar
vaccin
